SLCO1B1 variants in a patient of African ancestry presenting with rosuvastatin-induced rhabdomyolysis: A case report

被引：1
|
作者：
Medwid, Samantha [1 ]
Deckert, Rowan [1 ]
Gryn, Steven E. [1 ,2 ]
Kim, Richard B. [1 ,2 ,3 ,4 ]
机构：
[1] Univ Western Ontario, Dept Med, London, ON, Canada
[2] London Hlth Sci Ctr, London, ON, Canada
[3] Western Univ, Dept Physiol & Pharmacol, London, ON, Canada
[4] Lawson Hlth Res Inst, London, ON, Canada
来源：
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY | 2025年 / 91卷 / 01期
关键词：
statins; rhabdomyolysis; pharmacogenetics; DRUG; POLYMORPHISMS; TRANSPORTERS;
D O I：
10.1111/bcp.16329
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
We report a case of an adult woman of African ancestry who was hospitalized with statin induced- rhabdomyolysis. The patient presented to the emergency room with a 2-week history of worsening muscle pain, nausea, vomiting and low oral intake, 1 month after starting 40 mg daily dose of rosuvastatin. Sequencing of SLCO1B1 coding regions revealed the patient was heterozygous for two SLCO1B1 deleterious variants, c.481+1G>T and c.1463G>C (*9), which are more prevalent in patients of African ancestry. This highlights the importance of pharmacogenetic testing in SLCO1B1, which includes a broader range of genetic variants for patients of African ancestry.
引用
收藏
页码：232 / 235
页数：4
相关论文
共 50 条
  • [1] Effects of SLCO1B1 and GATM gene variants on rosuvastatin-induced myopathy are unrelated to high plasma exposure of rosuvastatin and its metabolites
    Bai, Xue
    Zhang, Bin
    Wang, Ping
    Wang, Guan-lei
    Li, Jia-li
    Wen, Ding-sheng
    Long, Xing-zhen
    Sun, Hong-shuo
    Liu, Yi-bin
    Huang, Min
    Zhong, Shi-long
    ACTA PHARMACOLOGICA SINICA, 2019, 40 (04) : 492 - 499
  • [2] Effects of SLCO1B1 and GATM gene variants on rosuvastatin-induced myopathy are unrelated to high plasma exposure of rosuvastatin and its metabolites
    Xue Bai
    Bin Zhang
    Ping Wang
    Guan-lei Wang
    Jia-li Li
    Ding-sheng Wen
    Xing-zhen Long
    Hong-shuo Sun
    Yi-bin Liu
    Min Huang
    Shi-long Zhong
    Acta Pharmacologica Sinica, 2019, 40 : 492 - 499
  • [3] Rosuvastatin-Induced Rhabdomyolysis: A Case Report
    Nikalji, Ravindra
    Sen, Suvadeep
    INDIAN JOURNAL OF NEPHROLOGY, 2021, 31 (02) : 190 - 193
  • [4] Atorvastatin-associated rhabdomyolysis in a patient with a novel variant of the SLCO1B1 gene: A case report
    Kiage, James
    Venkatanarayan, Ajay
    Roth, Mendel
    Elam, Marshall
    JOURNAL OF CLINICAL LIPIDOLOGY, 2022, 16 (01) : 23 - 27
  • [5] SLCO1B1 Variants and Statin-Induced Myopathy
    Vladutiu, Georgirene D.
    Isackson, Paul J.
    NEW ENGLAND JOURNAL OF MEDICINE, 2009, 360 (03): : 304 - 304
  • [6] Statin-induced rhabdomyolysis from azithromycin interaction in a patient with heterozygous SLCO1B1 polymorphism
    Burns, Hailey
    Russell, Landon
    Cox, Zachary L.
    JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS, 2021, 46 (03) : 853 - 855
  • [7] Rosuvastatin-Induced Rhabdomyolysis as a Result of Drug Interaction With Sitagliptin: A Case Report
    Atapour, Abdolamir
    Momenzadeh, Mahnaz
    Panahishokouh, Mahsa
    Badri, Shirinsadat
    CLINICAL MEDICINE INSIGHTS-CASE REPORTS, 2024, 17
  • [8] SLCO1B1 variants associated with statin-induced myopathy
    Nature Clinical Practice Cardiovascular Medicine, 2008, 5 (12): : 752 - 752
  • [9] SLCO1B1 521T > C polymorphism associated with rosuvastatin-induced myotoxicity in Chinese coronary artery disease patients: a nested case–control study
    Ju-E Liu
    Xiao-Ying Liu
    Sheng Chen
    Yan Zhang
    Li-Yun Cai
    Min Yang
    Wei-Hua Lai
    Bin Ren
    Shi-Long Zhong
    European Journal of Clinical Pharmacology, 2017, 73 : 1409 - 1416
  • [10] Different effects of SLCO1B1 polymorphism on the pharmacokinetics of atorvastatin and rosuvastatin
    Pasanen, M. K.
    Fredrikson, H.
    Neuvonen, P. J.
    Niemi, M.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2007, 82 (06) : 726 - 733
12345